Trialjectory, a startup that matches cancer patients to clinical trials, announced Monday it had raised $20 million in Series A funding.
The round was led by Insight Partners, with participation from JAL Ventures, Contour Venture Partners, Rho Capital and TIA Ventures.
WHAT IT DOES
The company offers an AI-enabled platform where patients can input information about their type of cancer and...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
